Jul 14, 2026 Presentations & Publications Randomized, Double-Blind, Placebo-Controlled First-in-Human Trial of a First-in-Class AI-Designed Monoclonal Antibody (GB-0669) Against the Conserved SARS-CoV‑2 Spike S2 Stem Helix Read More
Oct 09, 2025 Presentations & Publications First-in-Human Study of a First-in-Class AI-Designed Monoclonal Antibody (GB-0669) Against the Conserved SARS-CoV-2 Spike S2 Stem Helix View on: medRxiv
Sep 28, 2025 Presentations & Publications ERS 2025: GB-0895, a high-affinity anti-TSLP mAb, demonstrates prolonged half-life and sustained pharmacological activity supporting every 6-month dosing in asthma Read More
Apr 01, 2025 Presentations & Publications Functional and structural characterization of a combination of pan-sarbecovirus antibodies with potent antiviral activity View on: bioRxiv
Oct 15, 2024 Presentations & Publications IDWeek 2024: Machine learning-guided generation of a potent combination of broadly neutralizing sarbecovirus antibodies with a high barrier to resistance Read More
Oct 15, 2024 Presentations & Publications IDWeek 2024: First-in-human study of a novel half life extended monoclonal antibody (GB-0669) against SARS-CoV-2 and related sarbecoviruses Read More
Nov 15, 2023 Presentations & Publications Illuminating Protein Space With a Programmable Generative Model View on: Nature
Dec 06, 2022 Presentations & Publications Protein re-surfacing of E. coli L-Asparaginase to evade pre-existing anti-drug antibodies and hypersensitivity responses View on: Frontiers
